8h00
Registration and welcome coffee
8h45
Welcome Address
9h00
OPENING KEYNOTE LECTURES
John Lambert
Former Chief Scientific Officer, ImmunoGen, Inc. (retired 2018)
Honorary Professor, Queen's University Belfast, Northern Ireland
Consultant, Cambridge, Massachusetts, USA
John Lambert Consulting, USA
Prof. Kassoum Kayentao
University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali
10h00
Coffee Break - Exhibition Hall - B2B Meetings
10h30
Track What we have learnt from Non-Traditional Antibodies formats so far
Alain Beck
Senior Director
Biologics CMC & Developability, Pierre Fabre, France
Alexandra Ferrier
Senior Principal Scientist Group Head in Drug Conjugates Medicinal Chemistry
SANOFI, France
Peter Lowe
Director Antibody Engineering
Merus, The Netherlands
Anette Weyergang
Senior scientist at the Institute for Cancer Research
Oslo University Hospital, Norway
Manuel Pelé
Project Manager
MImAbs, France
Radhar Parmar
Science and technology consultant, biologics - EMEA
Twist Bioscience
Track Cell Therapy: new approaches
Michael Esquerré
Vice-President Immuno-Oncology, Immuno-Oncology Therapeutic Area lead
Evotec, France
Danièle Bensoussan
Co-founder
StemInov
PU-PH - Head of Cellular Therapy Unit and Tissue Bank
Cord Blood Bank (UTCT)
Head of a Research Unit
CNRS, France
12h10
Lunch break - Exhibition Hall - B2B Meetings
14h00
Track Isolating Human Antibodies from the Human Repertoire
Sandrine Legg
Director of Phenotypic Screening, Research
Alchemab Therapeutics Ltd, UK
Kai Kisand
University of Tartu, Estonia
Marielle Mazille
EMEAI Subject Matter Expert application Team Leader - Life Science
Revvity
Christophe Fleury
Science & Technology Advisor
10XGENOMICS, France
Track Tackling Toxicity of CART Treatments
Maik Luu
Junior Group Leader and Scientific Project Manager of T2EVOLVE
University Clinic Würzburg, Germany
Emmanuel Donnadieu
Group Leader
Institut Cochin, France
15h20
Coffee Break - Exhibition Hall - B2B Meetings
16h10
Pitch Session : Innovative Approaches and New trend Technologies
Anaïs Cornebois
PhD student
SANOFI & Centre en Cancérologie de Toulouse (CRCT)
Aurelie Drouin
Research Engineer, ISP UMR1282
Université de Tours
Cyril Clavel
Associate professor in Cell Biology
Infinity Inserm UMR1291 - Université Toulouse III
Dominik Stappert
Scientist and Project Manager, CRFS-LAT
German Center for Neurodegenerative Diseases (DZNE)
Esteban Lebrun
Post-doctoral researcher
INRAE - Micalis Institute
Louis Jolivet
PhD student
ISP UMR1282, Université de Tours
Vincent Delauzun
Research Scientist
CYTOBODX
17h30
POSTER Presentation - WINE & CHEESE
20h00
Cocktail Gala Dinner - Château Belmont
8h00
Welcome coffee
9h00
OPENING KEYNOTE LECTURES
Prof. Marc Humbert
Professor of Respiratory Medicine
Université Paris-Saclay, France
Prof. Dr. Georg Schett
Head of Department of Medicine 3 - Rheumatology and Immunology and Vice President Research
Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
10h00
Coffee Break - Exhibition Hall - B2B Meetings
10h30
Track Biotherapeutics in Clinic: when the clinic is reshuffling the cards
Marie-Thérèse Rubio
Professor in clinical immunology, stem cell transplantation, immunotherapy
CHRU Nancy, France
Thierry Schaeverbeke
Head of the Rheumatology Department and Coordinator of Clinical Research
CHU Bordeaux, France
Simone Mader
Junior Group Leader
Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center Ludwig-Maximilians University Munich, Germany
Eric Quèmeneur
Executive VP, CSO
Transgene, France
Yu-Chih Lin
Ph.D, Technical Specialist
Sino Biological
Track Overcoming Bioprocessing Challenges to go into Clinic
Session I
Sabrina Vollers
Senior Team Leader, Head of Functional and PK Bioanalytic
Ichno Sciences, Switzerland
Paule Hermet
Researcher
ICOSAGEN, Estonia
Jamison Grailer
Sr. Research Scientist, Team Leader of the R&D cell-based bioassay development group
PROMEGA
Géry Van Vyncht
Scientific Director, R&D and Innovation
Quality Assistance, Belgium
Luc-Alain Savoy
Global Head of Biologics
SGS, Switzerland
Claude Nogues
Scientific Director & Co-Founder
Kimialys
12h00
Lunch break - Exhibition Hall - B2B Meetings
14h00
Track MAbs Immunopharmacology, what's new?
George Kararigas
Professor
University of Iceland, Iceland
Aliki Peletidi
Pharmacy Programme Coordinator, Lecturer in Applied Pharmacy Practice, Pharmacy Programme, Department of Health Sciences
University of Nicosia, Cyprus
Konstatin Tachkov
Assistant Professor
Faculty of Pharmacy, Medical University of Sofia
David Ternant
Senior Lecturer
University of Tours, France
Track Overcoming Bioprocessing Challenges to go into Clinic
Session II
Gael Debauve
Head of Gene therapy CMC Analytics
UCB Pharma, Belgique
Nigel Shipston
Senior Director - Business Development
Just Evotec Biologics
Sylvain Julien
Director of Research Genetic Engineering
Polyplus, France
Marion Albasini
Business Developer
FidaBio, Denmark
15h20
CAR T cells : overview of a revolution
Elsa Kress
Head of Business Development
Mabdesign, France
15h35
Intellectual property and Biopharmaceuticals Round Table : Strategies to navigate an increasingly complex field
Loïc Lemercier
Associate and Head of IP & Technology
Dentons, France
Nicolas Bouquin
Senior Associate, European & French Partner Attorney
REGIMBEAU, France
Philippe Bessiere
Global Head of Patents
Pierre Fabre, France
16h20
Best Poster - Announcement of AIS2024
16h30
End of Congress
Organization contact
Ana Antunes
17 rue Crépet
69007 Lyon
+33 (0)6 26 33 63 21
ana-sofia.antunes@mabdesign.fr